Clinical Trials · NCT01368913

MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis

Name: MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/ADesmopressin

Phase: N/A
Recruitment status: Completed
Sponsor: Ferring Pharmaceuticals
Enrollment: 138
Start date: Jun 2011
Locations: 73 sites, Germany
Primary endpoint: Assessment of patient and parent satisfaction

View Desmopressin compound reference